Doximity [DOCS] vs HealthEquity [HQY] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Doximity Inc. wins in 8 metrics, HealthEquity Inc. wins in 12 metrics, with 0 ties. HealthEquity Inc. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Doximity Inc. | HealthEquity Inc. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 20.29 | 31.61 | Doximity Inc. |
| Price-to-Book Ratio | 4.56 | 3.14 | HealthEquity Inc. |
| Debt-to-Equity Ratio | 1.09 | 47.53 | Doximity Inc. |
| PEG Ratio | -1.16 | 0.34 | HealthEquity Inc. |
| EV/EBITDA | 15.22 | 15.04 | HealthEquity Inc. |
| Profit Margin (TTM) | 37.54% | 16.39% | Doximity Inc. |
| Operating Margin (TTM) | 38.89% | 21.64% | Doximity Inc. |
| EBITDA Margin (TTM) | 38.89% | 21.64% | Doximity Inc. |
| Return on Equity | 23.82% | 10.19% | Doximity Inc. |
| Return on Assets (TTM) | 12.84% | 5.99% | Doximity Inc. |
| Free Cash Flow (TTM) | $266.74M | $408.32M | HealthEquity Inc. |
| 1-Year Return | -58.92% | -12.54% | HealthEquity Inc. |
| Price-to-Sales Ratio (TTM) | 7.13 | 5.00 | HealthEquity Inc. |
| Enterprise Value | $3.74B | $7.25B | HealthEquity Inc. |
| EV/Revenue Ratio | 5.86 | 5.52 | HealthEquity Inc. |
| Gross Profit Margin (TTM) | 89.89% | 68.19% | Doximity Inc. |
| Revenue per Share (TTM) | $3 | $15 | HealthEquity Inc. |
| Earnings per Share (Diluted) | $1.19 | $2.46 | HealthEquity Inc. |
| Beta (Stock Volatility) | 1.42 | 0.26 | HealthEquity Inc. |
| Short % of Float | 10.09% | 4.74% | HealthEquity Inc. |
Doximity Inc. vs HealthEquity Inc. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Doximity Inc. | -2.19% | 3.85% | -15.47% | -21.99% | -59.17% | -51.40% |
| HealthEquity Inc. | -3.54% | -1.56% | 3.69% | 5.94% | -13.62% | -6.43% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Doximity Inc. | -58.92% | -35.21% | -61.77% | -61.77% | -61.77% | -61.77% |
| HealthEquity Inc. | -12.54% | 48.48% | 8.50% | 230.05% | 419.12% | 419.12% |
Performance & Financial Health Analysis: Doximity Inc. vs HealthEquity Inc.
| Metric | DOCS | HQY |
|---|---|---|
| Market Information | ||
| Market Cap | $4.36B | $6.57B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 3,524,245 | 1,020,070 |
| 90 Day Avg. Volume | 2,884,808 | 1,022,103 |
| Last Close | $21.04 | $85.21 |
| 52 Week Range | $17.15 - $76.51 | $72.76 - $116.65 |
| % from 52W High | -72.50% | -26.95% |
| All-Time High | $107.79 (Sep 06, 2021) | $116.65 (Jun 05, 2025) |
| % from All-Time High | -80.48% | -26.95% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.10% | 0.07% |
| Quarterly Earnings Growth | -0.18% | 0.89% |
| Financial Health | ||
| Profit Margin (TTM) | 0.38% | 0.16% |
| Operating Margin (TTM) | 0.39% | 0.22% |
| Return on Equity (TTM) | 0.24% | 0.10% |
| Debt to Equity (MRQ) | 1.09 | 47.53 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $5.29 | $24.79 |
| Cash per Share (MRQ) | $3.98 | $3.78 |
| Operating Cash Flow (TTM) | $315.42M | $457.09M |
| Levered Free Cash Flow (TTM) | $213.63M | $338.05M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Doximity Inc. vs HealthEquity Inc.
| Metric | DOCS (Apr 24, 2026) | HQY (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 20.29 | 31.61 |
| Forward P/E | 14.90 | 14.56 |
| PEG Ratio | -1.16 | 0.34 |
| Price to Sales (TTM) | 7.13 | 5.00 |
| Price to Book (MRQ) | 4.56 | 3.14 |
| Market Capitalization | ||
| Market Capitalization | $4.36B | $6.57B |
| Enterprise Value | $3.74B | $7.25B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 5.86 | 5.52 |
| Enterprise to EBITDA | 15.22 | 15.04 |
| Risk & Other Metrics | ||
| Beta | 1.42 | 0.26 |
| Book Value per Share (MRQ) | $5.29 | $24.79 |
Financial Statements Comparison: Doximity Inc. vs HealthEquity Inc.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | DOCS (2025) | HQY (2026) |
|---|---|---|
| Revenue/Sales | 570.40M | 1.31B |
| Cost of Goods Sold | 55.87M | 400.31M |
| COGS % of Revenue | 9.8% | 30.5% |
| Gross Profit | 514.53M | 913.12M |
| Gross Margin | 90.2% | 69.5% |
| Research & Development | 93.04M | 262.51M |
| Operating Income (EBIT) | 230.10M | 327.48M |
| Operating Margin | 40.3% | 24.9% |
| EBITDA | 242.90M | 494.24M |
| EBITDA Margin | 42.6% | 37.6% |
| Pre-Tax Income | 263.57M | 277.43M |
| Pre-Tax Income % of Revenue | 46.2% | 21.1% |
| Income Tax | 40.39M | 62.23M |
| Income Tax % of Revenue | 7.1% | 4.7% |
| Net Income (Profit) | 223.19M | 215.20M |
| Profit Margin | 39.1% | 16.4% |
Balance Sheet & Liquidity Metrics
| Metric | DOCS (2025) | HQY (2026) |
|---|---|---|
| Cash & Equivalents | 209.61M | 318.93M |
| Total Current Assets | 1.09B | 512.28M |
| Total Current Assets % of Revenue | 190.9% | 39.0% |
| Total Current Liabilities | 156.26M | 156.85M |
| Total Current Liabilities % of Revenue | 27.4% | 11.9% |
| Long-Term Debt | 10.19M | 991.57M |
| Long-Term Debt % of Revenue | 1.8% | 75.5% |
| Total Shareholders Equity | 1.08B | 2.11B |
| Retained Earnings | 186.89M | 195.91M |
| Retained Earnings % of Revenue | 32.8% | 14.9% |
| Property, Plant & Equipment | 8.89M | 36.31M |
Cash Flow Statement Comparison
| Metric | DOCS (2025) | HQY (2026) |
|---|---|---|
| Operating Cash Flow | 279.85M | 457.11M |
| Operating Cash Flow % of Revenue | 49.1% | 34.8% |
| Capital Expenditures | 0 | -1.97M |
| Free Cash Flow | 266.74M | 408.32M |
| FCF Margin | 46.8% | 31.1% |
| Debt Repayment | N/A | -100.00M |
| Common Stock Repurchase | -120.29M | -299.25M |
Short Interest & Institutional Ownership Analysis
| Metric | DOCS | HQY |
|---|---|---|
| Shares Short | 13.20M | 3.45M |
| Short Ratio | 4.99 | 3.52 |
| Short % of Float | 10.09% | 4.74% |
| Shares Outstanding | 184.99M | 85.01M |
| Float Shares | 130.57M | 82.74M |
| % Held by Insiders | 2.59% | 2.32% |
| % Held by Institutions | 93.77% | 109.95% |
| % Held by Public | 3.64% | -12.27% |
Dividend Analysis & Yield Comparison: Doximity Inc. vs HealthEquity Inc.
| Metric | DOCS | HQY |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |